Characteristic | Number (% of total) |
---|---|
Questionnaires completed | 127 (100%) |
General patient information | |
Sex | |
Male | 24 (19%) |
Female | 103 (81%) |
Age | |
Younger than 45 years | 14 (11%) |
45 to 60 years | 45 (35%) |
Older than 60 | 67 (53%) |
No answer | 1 (1%) |
First occurrence of RA symptoms | |
Before the age of 30 | 28 (22%) |
Between the age of 30 and 40 | 19 (15%) |
Between the age of 40 and 50 | 28 (22%) |
Between the age of 50 and 60 | 38 (30%) |
After the age of 60 | 13 (10%) |
No answer | 1 (1%) |
Disease duration1 | |
Median (IQR) [years] | 8.5 (4–13) |
≤3 years | 18 (14%) |
4 to 10 years | 30 (24%) |
≥11 years | 28 (22%) |
No answer | 51 (40%) |
Severity of RA | |
Mild | 18 (14%) |
Moderate | 80 (63%) |
Severe | 26 (21%) |
No answer | 3 (2%) |
Medical care | |
Satisfaction with information received from physician during diagnostic process | |
Very satisfied | 65 (51%) |
Satisfied | 30 (24%) |
Neutral | 17 (13%) |
Not particularly happy | 9 (7%) |
Completely dissatisfied | 4 (3%) |
No answer | 2 (2%) |
Patient was included in therapeutic decision making by physician | |
Yes | 105 (83%) |
No | 16 (13%) |
Current medications | |
Methotrexate | 77 (61%) |
Leflunomide | 13 (10%) |
Sulphasalazine | 7 (6%) |
Chloroquine/hydrochloroquine | 4 (3%) |
Concomitant glucocorticoids | 56 (44%) |
Biologics | 36 (28%) |
Alternative or complementary remedies | 17 (13%) |